FBXO22 and breast carcinoma: Deletion of Fbxo22 itself does not affect the growth of T47D breast cancer tumors in female NOD/Scid mice and only slightly reduces the proliferation and clone abilities of MDA-MB 231 cells (Johmura et al. 2018; Bai et al. 2019).